Pharmacovigilance (PV) organizations today face significant challenges and opportunities:

  • Explosive growth in case volume, often without commensurate resource increases
  • Changing regulatory requirements and lack of harmonization across regions
  • Availability of big data but difficulty leveraging it to support proactive drug safety and signal detection
  • Complex technology environment with new platforms offering significant capabilities beyond traditional drug safety databases
  • Increasing collaboration with partners and internal corporate functions

Satori’s pharmacovigilance offerings support clients in overcoming their challenges and realizing their opportunities: